CVS Health (NYSE: CVS) reported Q1 EPS of $2.57, $0.36 better than the analyst estimate of $2.21. Revenue for the quarter came in at $100.4 billion versus the consensus estimate of $95.02 billion.

GUIDANCE:

CVS Health sees FY2026 EPS of $7.30-$7.50, versus the consensus of $7.16.

For earnings history and earnings-related data on CVS Health (CVS) click here.